BLK 351.48 Blackrock $BLK Hit a 52 week high of 352.55

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
BLK 351.48 Blackrock $BLK Hit a 52 week high of 352.55 Currently at 351.48 +3.85 +1.11% With a day low of 346.16 and a total volume of 732,300.

BLK Blackrock Recent Headline News

BlackRock Rises 1.11% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Nov 07, 3:52PM CST
BlackRock (NYSE:BLK) traded in a range yesterday that spanned from a low of $346.16 to a high of $352.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $348.25 on volume of 711,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BLK: 351.48 (+3.85)

SmarTrend Watching for Potential Pullback in Shares of BlackRock After 1.11% Gain
Comtex SmarTrend(R) - Fri Nov 07, 3:52PM CST
BlackRock (NYSE:BLK) traded in a range yesterday that spanned from a low of $346.16 to a high of $352.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $348.25 on volume of 711,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BLK: 351.48 (+3.85)

Stocks Hold Near Break-Even; Wal-Mart, BlackRock Rise
at Investor's Business Daily - Fri Nov 07, 12:26PM CST
Stocks lingered just above or below the break-even line in early-afternoon trade Friday. The Nasdaq was 0.2% in the red, trimmed from a first-hour 0.7% loss. The S&P 500 and the Dow Jones industrial average gripped gains of less than 0.1%. Volume in...
BLK: 351.48 (+3.85), WMT: 78.77 (+0.96), BABA: 114.56 (+2.99)

Alibaba (BABA): What Mutual Funds Are the Biggest Holders? - Mutual Fund Commentary
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 10:39AM CST
In the Alibaba IPO, mutual funds scored over hedge funds as the former is heavily regulated and have to make more disclosures.
BLK: 351.48 (+3.85), TROW: 83.23 (+0.78), BABA: 114.56 (+2.99)

Cash America's Enova Spinoff Is Another Way to Play Online Lending
at The Street - Thu Nov 06, 1:44PM CST
Online lending fans are eagerly awaiting the IPO of LendingClub, but another investment that may prove more attractive will begin trading Nov. 13.
BLK: 351.48 (+3.85), CS: 25.84 (+0.13), MS: 35.66 (+0.35), CSH: 49.15 (+0.02)

Morning Briefing on Asset Management and Custody Banks Stocks - Apollo Global Management, Och-Ziff Capital Management, Apollo Investment, Ameriprise Financial, and BlackRock
PR Newswire - Thu Nov 06, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Apollo Global Management LLC (NYSE: APO), Och-Ziff Capital Management Group LLC (NYSE: OZM), Apollo Investment Corporation (NASDAQ: AINV), Ameriprise Financial Inc. (NYSE: AMP), and BlackRock Inc. (NYSE: BLK). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, November 05, 2014, mostly ended on a higher note as the Dow Jones Industrial Average finished at 17,484.53, up 0.58% and the NASDAQ Composite closed at 4,620.72, down 0.06%. The S&P 500 finished the session 0.57% higher at 2,023.57. During the trading session, nine out of ten sectors finished on a positive note. The S&P 500 Financials Sector Index ended the day at 324.54, up 0.63%, with the index advancing 8.68% in the previous three months. Register for your complimentary reports on these five stocks at:
APO: 23.38 (+0.80), BLK: 351.48 (+3.85), AINV: 8.31 (+0.16), AMP: 129.05 (+0.16), OZM: 11.28 (+0.13)

How Shanghai's Stock Connect Is Opening China's Stock Market to Foreign Investors
at The Street - Thu Nov 06, 5:05AM CST
China is poised to let the Shanghai-listed shares of 568 big Chinese companies trade on the Hong Kong exchange. But that will eventually weaken foreign institutions with special quotas.
BLK: 351.48 (+3.85), IVZ: 41.28 (+0.33)

Why Affiliated Managers Fell Despite Q3 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 8:10AM CST
Following the third-quarter 2014 earnings release, shares of Affiliated Managers (AMG) declined more than 3.3%. The fall came on growing concerns over persistent rise in operating expenses, in spite of reporting upbeat results before the opening bell.
LAZ: 49.30 (-0.73), AMG: 196.70 (+1.50), BLK: 351.48 (+3.85), IVZ: 41.28 (+0.33)

Why is Fortress Investment Up Despite Q3 Earnings Miss? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 12:00PM CST
Higher expenses dragged results of Fortress Investment Group LLC (FIG) and it consequently failed to deliver a positive earnings surprise
SEIC: 39.24 (+0.09), FIG: 7.32 (-0.03), BLK: 351.48 (+3.85), AMP: 129.05 (+0.16)

Apollo Global (APO) Q3 Earnings Miss on Lower Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:50AM CST
Dismal performance in the private equity segment dragged third-quarter 2014 results of Apollo Global Management, LLC (APO)
SEIC: 39.24 (+0.09), APO: 23.38 (+0.80), BLK: 351.48 (+3.85), AMP: 129.05 (+0.16)

BlackRock (BLK) Stock Climbs on Analyst Upgrade Today
at The Street - Mon Nov 03, 7:48AM CST
BlackRock (BLK) stock is higher this morning after the company was upgraded to 'buy' from 'neutral' at Citigroup.
BLK: 351.48 (+3.85)

Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy
PR Newswire - Mon Nov 03, 7:40AM CST
Today, Analysts Review released its research reports regarding AFLAC Inc. (NYSE: AFL), BlackRock, Inc (NYSE: BLK), Allergan Inc. (NYSE: AGN), Cabot Oil & Gas Corporation (NYSE: COG) and Cheniere Energy, Inc. (NYSEMKT: LNG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7630-100free.
AGN: 196.00 (-1.40), COG: 33.62 (+0.92), BLK: 351.48 (+3.85), LNG: 71.95 (+1.18), AFL: 58.89 (-0.64)

Upgrade Alert for BlackRock (BLK)
Comtex SmarTrend(R) - Mon Nov 03, 7:02AM CST
BlackRock (NYSE:BLK) was upgraded from Neutral to Buy at Citigroup today. The stock closed yesterday at $341.11 on volume of 761,000 shares, above average daily volume of 680,000. In the past 52 weeks, BlackRock share prices have been bracketed by a low of $284.78 and a high of $342.22 and closed yesterday at $341.11, 20% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has risen 0.2%.
BLK: 351.48 (+3.85)

Legg Mason Fiscal Q2 Earnings Beat on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:00PM CDT
Driven by higher revenues, Legg Mason Inc.'s (LM) fiscal second-quarter 2015 adjusted earnings came in at 35 cents per share, beating the Zacks Consensus Estimate of 33 cents
BX: 31.14 (+0.84), BLK: 351.48 (+3.85), LM: 54.23 (-0.22), WDR: 48.52 (+0.46)

Stocks Hold On To Most Of Day's Gains As Financials Rally
at Investor's Business Daily - Fri Oct 31, 12:34PM CDT
The stock market held on to most of Friday's surge in early afternoon trading, as the major indexes gained 1% or more. The Nasdaq was up 1.3%, with solar and techs helping lead the way, while the S&P 500 and the Dow Jones industrial average added 1%....
BLK: 351.48 (+3.85), HDB: 51.84 (-1.05), EEFT: 54.22 (+0.03)

Invesco (IVZ) Beats Q3 Earnings on Revenue & AUM Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 2:00PM CDT
Driven by strong top-line growth and net inflows, Invesco (IVZ) reported third-quarter 2014 adjusted earnings of 64 cents per share. It surpassed the Zacks Consensus Estimate by 2 cents, marking the fifth consecutive earnings beat.
BX: 31.14 (+0.84), BLK: 351.48 (+3.85), IVZ: 41.28 (+0.33), WDR: 48.52 (+0.46)

BlackRock Global Investor Pulse Survey: Despite Strengthening U.S. Economic Growth, Americans "Holding Back" as Investors
Business Wire - Thu Oct 30, 9:37AM CDT
Despite improved prospects for U.S. growth, Americans are still "holding back" as investors and potentially risking their financial future, particularly hopes for a secure retirement, according to results of the BlackRock (NYSE:BLK) Global Investor Pulse Survey.
BLK: 351.48 (+3.85)

Is WisdomTree Investments Inc. Finally Poised for a Turnaround?
Dan Caplinger, The Motley Fool - Motley Fool - Thu Oct 30, 7:05AM CDT
Source: WisdomTree. Finding smart investments is one of the hardest tasks an investor faces. Sometimes, it pays to invest in the companies that make it their job to provide investment options to millions of investors across the world. WisdomTree...
BLK: 351.48 (+3.85), JNS: 15.31 (+0.54), WETF: 15.60 (-0.11), SCHW: 28.58 (-0.46)

BlackRock Survey: Canadians Prioritize Long-Term Financial Goals, but Their Short-Term Actions Are a Barrier to Reaching Them
Marketwired - Thu Oct 30, 6:09AM CDT
Editors Note: There is a video and an image accompanying this press release.
BLK: 351.48 (+3.85)

Ameriprise's Q3 Earnings Beat on Revenue & AUM Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:40AM CDT
Ameriprise (AMP) reported third-quarter 2014 adjusted operating earnings per share of $2.24, outpacing the Zacks Consensus Estimate of $1.95. Moreover, the figure came in 28% above the year-ago quarter.
BX: 31.14 (+0.84), BLK: 351.48 (+3.85), TROW: 83.23 (+0.78), AMP: 129.05 (+0.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 218

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 160

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 61

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 225

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

McKinney's New Consumer PR Practice Sparks Marketing Buzz

Updated Category News Views 217

Market Dynamics Shifting: McKinney's Bold Move Let’s cut to the chase: McKinney’s launching a consumer PR practice—big deal, right? Well, hold your horses. This ain't just another agency spitting out press releases. They’re bringing in Jae Siercks, a heavy hitter from Weber Shandwick, to lead the charge. This kind of strategy echoes back to the days of the dot-com...

Continue Reading
Pariveda's Commitment: Winning Social Impact Partner Award

Updated Category News Views 218

Pariveda Recognized as Social Impact Partner of the Year Pariveda is proud to announce its recognition as the winner of the 2025 Geography and Global AWS Partner Award, highlighting its significant role as an innovator in the technology space. This prestigious award showcases the dedication of AWS Partners worldwide in advancing solutions using Amazon Web Services (AWS)....

Continue Reading
Eric A. Seiff: Celebrated Advocate in Criminal Defense for 2024

Updated Category News Views 179

Back in 2024, Eric A. Seiff was recognized among America’s Top 100 Criminal Defense Attorneys—a title only given to the absolute cream of the crop, with fewer than 0.5% of practicing attorneys making the cut. You gotta appreciate that level of distinction; it ain't just about being good—it’s about years spent fighting tooth and nail for what’s right in a...

Continue Reading
Wells Fargo Raises Price Target for Morgan Stanley Stock

Updated Category News Views 147

Wells Fargo Adjusts Morgan Stanley's Stock Outlook Recently, Wells Fargo reviewed its stance on Morgan Stanley (NYSE: MS), increasing the price target from $95.00 to $107.00. While this adjustment is a positive sign, the firm decided to keep an Underweight rating on the stock. The increase in the price target comes after Morgan Stanley's performance in the third quarter,...

Continue Reading
Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief

Updated Category News Views 218

Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief Raytone Biotech, a clinical-stage biotechnology company focused on innovative ophthalmic therapies, recently achieved a significant milestone by successfully completing the first patient dosing in its clinical trial for RTP-008. This new therapy is purposefully designed for those suffering from dry eye...

Continue Reading